We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

World-first "Fast-fail" Trial Examines Loss of Pleasure in Mood Disorders

News   Mar 31, 2020 | Original story from the NIH

 
World-first "Fast-fail" Trial Examines Loss of Pleasure in Mood Disorders

Credit: Photo by Maksym Kaharlytskyi on Unsplash https://unsplash.com/@qwitka

 
 
Advertisement
 

RELATED ARTICLES

Hydroxychloroquine Trial Revived by WHO as Doubt Cast on Lancet, NEJM Studies

News

Testing of the malaria drug hydroxychloroquine as a treatment for COVID-19 has been restarted by the WHO after researchers raised concerns about the paper, published in The Lancet two weeks ago, that first suggested the drug was linked to reduced survival and a higher risk of heart-related side effects.

READ MORE

First Structures of α-synuclein Filaments From Human Brain

News

Researchers have revealed the first structures of α-synuclein filaments from human brain, which may benefit diagnosis and treatment of neurodegenerative synucleinopathies.

READ MORE

Why Developing Nerve Cells Can Take a Wrong Turn

News

Researchers have uncovered a link between the cellular machineries of protein degradation, regulation of the epigenetic landscape and neurodevelopment.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE